Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Behavioral phenotypes associated with cannabis and alcohol substitution

AI Summary
  • Within-subject crossover lab study compared alcohol self-administration after cannabis versus without cannabis to classify behavioural phenotypes: substituters, complementers, non-substituters.
  • Substituters (n=23) showed lower negative emotionality and lower impulsivity versus non-substituters on BDI-II, DASS-Depression, and UPPS-P lack of premeditation.
  • Higher positive cannabis expectancies were noted among substituters but not statistically significant; further research needed on long-term substitution outcomes.
Summarise with AI (MRCPsych/FRANZCP)

Harm Reduct J. 2026 Mar 6. doi: 10.1186/s12954-026-01432-y. Online ahead of print.

ABSTRACT

OBJECTIVE: Alcohol and cannabis co-use is the most common form of polysubstance use in the U.S. Some evidence suggests that there is an association between cannabis use and reduced alcohol consumption, however data on this topic are mixed. Further research is needed to elucidate the individual factors that determine whether cannabis substitutes for alcohol.

METHOD: This study is an exploratory analysis of data from a within-subjects, crossover laboratory study on alcohol and cannabis co-administration. Participants completed two sessions: one in which they self-administered alcohol after using cannabis, and one in which they self-administered alcohol but did not use cannabis. We aim to compare behavioral phenotypes of individuals who self-administered less alcohol after cannabis (“substituters”; n = 23), more alcohol after cannabis (“complementers”; n = 7), or the same amount of alcohol regardless of whether cannabis was used (“non-substituters”; n = 16). We utilized Welch’s ANOVAs and Kruskal-Wallis tests to compare baseline group differences, drawing on domains from the Addictions Neuroclinical Assessment (ANA) framework. Wilcoxon tests were employed to test differences in laboratory self-administration measures between sessions for each group.

RESULTS: Substituters had significantly lower scores on measures corresponding to ANA domains of negative emotionality (BDI-II, DASS-Depression) and executive function (UPPS-P Lack of Premeditation) than non-substituters. Substituters endorsed higher positive cannabis expectancies than non-substituters, though expectancy differences did not reach significance.

CONCLUSIONS: Individuals who use cannabis and alcohol and have lower levels of negative emotionality and impulsivity may be more likely to substitute cannabis for alcohol. Future research is needed to explore long-term outcomes of cannabis substitution.

CLINICAL TRIALS REGISTRATION NUMBER: NCT04998006.

PMID:41792806 | DOI:10.1186/s12954-026-01432-y

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD